Observational studyAesthetic plastic surgery2026
Weighing the Risk: The Impact of Obesity on 30-Day Complications After Cosmetic Abdominoplasty-An Observational Cohort Study of 1,778 Cases.
Observational study in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Donor-site Seroma in Deep Inferior Epigastric Perforator Flap Breast Reconstruction: A Pooled Analysis.Plastic and reconstructive surgery. Global open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity's impact on postoperative outcomes in abdominoplasty remains poorly defined despite its rising prevalence. This study evaluates the effect of obesity on 30-day postoperative complications to inform risk assessment and management.
objectivesInvestigate the effect of obesity on 30-day postoperative complications following abdominoplasty.
methodsWe analyzed data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) for patients who underwent abdominoplasty between 2008 and 2022. Patients were categorized into obese (BMI ≥ 30 kg/m
resultsA total of 1,778 patients were included; 618 (34.8%) had obesity (mean BMI 35.2 ± 5.0 kg/m
conclusionObesity is an independent risk factor for complications following abdominoplasty. Optimized preoperative screening, potentially including DVT prophylaxis for patients with obesity, and tailored perioperative care are essential to improving outcomes in this population. Evidence-based guidelines are needed to enhance surgical safety for obese patients. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41201611What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.